Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Therapeutic Advances in Drug Safety
|
April 28, 2025
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System
Nunzia Balzano, Annamaria Mascolo, Donatella Ruggiero, et al.
Pharmacological Reports : PR
|
October 22, 2024
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database
Annamaria Mascolo, Alessia Zinzi, Mario Gaio, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
June 25, 2026
Spontaneous coronary artery dissection and sudden cardiac arrest: a reversible event or an indication for secondary prevention?
Giacomo Mugnai, Pietro Francia, Laura Perrotta, et al.
JACC. Clinical Electrophysiology
|
June 19, 2026
Selective Use of Nonselective Beta-Blockers: A Tailored Antiarrhythmic Approach
Davide Genovese, Giuseppe Sgarito, Donatella Ruggiero, et al.
Scientific Reports
|
November 29, 2025
A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use
Alessia Zinzi, Mario Gaio, Donatella Ruggiero, et al.
Heart Rhythm
|
August 27, 2025
Flecainide in Structural Heart Diseases: A Contemporary Reappraisal Beyond the CAST Trial
Davide Genovese, Micheal Salama, Donatella Ruggiero, et al.
Journal of the American College of Cardiology
|
December 11, 2012
A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure
Gianluigi Savarese, Pierluigi Costanzo, John George Franklin Cleland, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
May 14, 2014
[Endothelial function as a marker of pre-clinical atherosclerosis: assessment techniques and clinical implications]
Donatella Ruggiero, Stefania Paolillo, Giuseppe Della Ratta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 21, 2023
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?
Annamaria Mascolo, Liberata Sportiello, Concetta Rafaniello, et al.
Angiology
|
June 27, 2014
Prevalence and severity of asymptomatic coronary and carotid artery disease in patients with abdominal aortic aneurysm
Fabio Marsico, Giuseppe Giugliano, Donatella Ruggiero, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Therapeutic Advances in Drug Safety
|
April 28, 2025
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System
Nunzia Balzano, Annamaria Mascolo, Donatella Ruggiero, et al.
Pharmacological Reports : PR
|
October 22, 2024
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database
Annamaria Mascolo, Alessia Zinzi, Mario Gaio, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
June 25, 2026
Spontaneous coronary artery dissection and sudden cardiac arrest: a reversible event or an indication for secondary prevention?
Giacomo Mugnai, Pietro Francia, Laura Perrotta, et al.
JACC. Clinical Electrophysiology
|
June 19, 2026
Selective Use of Nonselective Beta-Blockers: A Tailored Antiarrhythmic Approach
Davide Genovese, Giuseppe Sgarito, Donatella Ruggiero, et al.
Scientific Reports
|
November 29, 2025
A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use
Alessia Zinzi, Mario Gaio, Donatella Ruggiero, et al.
Heart Rhythm
|
August 27, 2025
Flecainide in Structural Heart Diseases: A Contemporary Reappraisal Beyond the CAST Trial
Davide Genovese, Micheal Salama, Donatella Ruggiero, et al.
Journal of the American College of Cardiology
|
December 11, 2012
A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure
Gianluigi Savarese, Pierluigi Costanzo, John George Franklin Cleland, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
May 14, 2014
[Endothelial function as a marker of pre-clinical atherosclerosis: assessment techniques and clinical implications]
Donatella Ruggiero, Stefania Paolillo, Giuseppe Della Ratta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 21, 2023
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?
Annamaria Mascolo, Liberata Sportiello, Concetta Rafaniello, et al.
Angiology
|
June 27, 2014
Prevalence and severity of asymptomatic coronary and carotid artery disease in patients with abdominal aortic aneurysm
Fabio Marsico, Giuseppe Giugliano, Donatella Ruggiero, et al.
Page
of 3